99% Raw Peptide Powder Retatrutide Weight Loss Peptide API Raw Powder Retatrutide for Obesity Lyophilized Peptide Reta Retatrutide for Weight Loss

• Customization: Available
• CAS No.: 2381089-83-2
• Formula: N/a
• Model NO.: Reta
• EINECS: N/a
• Type: Synthesis Material Intermediates
• Appearance: Powder
• Quality: Refined
• Colour: White
• Content: Standard
• Source: Dry Powder
• Application: Scientific Research
• Property: Protein and Peptide
• Grade: Research Use
• Name: Retatrutide
• CAS: 2381089-83-2
• Note: No Tfa Salt
• From: Authoried Regluar Workshop
• Raw Powder: 1g/Bottle
• Attention: Research Use Only
• Transport Package: Customized
• Specification: 1G/Bottle
• Trademark: Hoconbio
• Origin: China
• Production Capacity: 5kg Per Month

Product Description

Retatrutide is a triple hormone (GIP, GLP-1 and glucagon) receptor agonist in development for the treatment of obesity.

Retatrutide is a next-generation peptide that targets multiple receptors in the body to help control blood sugar, reduce appetite, and promote fat loss.Unlike other weight-loss drugs, Retatrutide affects several pathways, offering a broader approach to weight management.

Retatrutide is especially helpful for individuals with type 2 diabetes or those seeking significant weight loss.Its multi-receptor approach is beneficial for people dealing with metabolic health issues as well as weight management.

Side Effects

Both treatments share similar side effects, such as nausea, vomiting, and digestive discomfort.Retatrutide may cause minor blood sugar fluctuations due to its effect on glucagon.

Product Name	Retatrutide
CAS NO.	2381089-83-2
Other name	LY3437943 GIPR/GLP-1R
Appearance	White powder
Purity	98% HPLC
Application	Research peptides
Shelf Life	24 Months
Storage	Store at a temperature of 2-8 degrees, protected from light.

1. Treatment of depression and anxiety disorders: Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
2. Prevention of neurodegenerative diseases: Retatrutide has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
3. Enhancement of cognitive function: Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
4. Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
5. Promotion of wound healing: Retatrutide has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.